The federal government’s proposed drug testing trial for selected unemployment benefits claimants has been greeted with depressingly predictable objections from the usual suspects. The two year trial commencing in 2018 will target approximately five thousand Newstart recipients. Individuals testing positive will trigger a range of outcomes including a limiting of the amount of welfare available to them as cash, repeat drug testing, and/or referral to a clinician for a treatment activity.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in